NEVVI Medicare utilization intelligence
or

← back

Provider profile

JUNG, KYUNGSUK MD MPH

Hematology-Oncology · NPI 1265792196 · SPRINGFIELD, IL

1
Groups
60
Codes · 2024
69,873
Disclosed services

JUNG, KYUNGSUK is a Hematology-Oncology in SPRINGFIELD, IL, a member of 1 medical group, who billed 60 distinct codes to Medicare Part B in 2024.

Groups: NORTHWEST MEDICAL SPECIALTIES PLLC (TACOMA, WA)

Year: 2024 · 2023 · 2020 🔒

Provider overview · all codes · CY2024

69,873
disclosed services
60
codes billed to Medicare Part B
Prior year · CY2023 5,368 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J1453 Injection, fosaprepitant, 1 mg
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
J0897 Injection, denosumab, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J2469 Injection, palonosetron hcl, 25 mcg
J2405 Injection, ondansetron hydrochloride, per 1 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
36415 Insertion of needle into vein for collection of blood sample
80053 Blood test, comprehensive group of blood chemicals
Q5108 Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg
96375 Injection of additional new drug or substance into vein
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96372 Injection of drug or substance under skin or into muscle
82784 Gammaglobulin (immune system protein) measurement
96413 Administration of chemotherapy into vein, 1 hour or less
J9045 Injection, carboplatin, 50 mg
J9190 Injection, fluorouracil, 500 mg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J3489 Injection, zoledronic acid, 1 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96415 Administration of chemotherapy into vein, each additional hour
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
J1200 Injection, diphenhydramine hcl, up to 50 mg
83615 Lactate dehydrogenase (enzyme) level
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
82728 Ferritin (blood protein) level
83540 Iron level
84466 Transferrin (iron binding protein) level
96417 Administration of additional new drug or substance into vein, 1 hour or less
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
96361 Infusion into a vein for hydration, each additional hour
96523 Irrigation of implanted venous access drug delivery device
82607 Cyanocobalamin (vitamin b-12) level
82746 Folic acid level, serum
96360 Infusion into a vein for hydration, 31-60 minutes
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
J7030 Infusion, normal saline solution , 1000 cc
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
82248 Bilirubin level, direct
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96374 Injection of drug or substance into vein
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
84443 Blood test, thyroid stimulating hormone (tsh)
86704 Hepatitis b core antibody measurement
86706 Hepatitis b surface antibody measurement
86708 Measurement of hepatitis a antibody
86803 Hepatitis c antibody measurement
87340 Detection test by immunoassay technique for hepatitis b surface antigen
96411 Administration of additional new drug or substance into vein using push technique
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
84153 Psa (prostate specific antigen) measurement, total
J3480 Injection, potassium chloride, per 2 meq
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.